Skip to main content
. 2020 Dec 8;9(24):e018897. doi: 10.1161/JAHA.120.018897

Figure 1. Major mechanisms of action of statins, ezetimibe, and PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitors.

Figure 1

HMG CoA indicates hydroxy‐3‐methyglutaryl coenzyme A; LDL, low‐density lipoprotein; LDL‐C, LDL cholesterol; LDLR, LDL receptor; and NPC1L1, Niemann‐Pick C1 like.